Skip to Content
eLife home page
Submit my research
(via ORCID - An ORCID is a persistent digital identifier for researchers)
Search the eLife site
Search by keyword or author
Webinar Report: Preprinting in medicine
In this webinar our speakers discussed their experiences of publishing clinical and health research as preprints.
eLife Latest: The diversity of our editorial community
A first-of-its-kind survey of eLife editors helps reveal how much our editorial boards reflect the diverse research communities that we serve.
Early-career reviewers: Opportunities for structural biologists and molecular biophysicists
eLife is recruiting early-career researchers to review manuscripts in Structural Biology and Molecular Biophysics; closing date is 17 June.
Early-Career Advisory Group: Election results 2021
The election of five new members will help ECAG in its efforts to reform research communication and research culture.
eLife Latest: The MDAR Framework – a new tool for life sciences reporting
A group of journal editors and researchers have developed the new MDAR Framework to help improve reporting and, in turn, drive research improvement and ultimately greater trust in science.
eLife Latest: Authors can now submit a manuscript to the journal and medRxiv at the same time
As eLife transitions to exclusively reviewing preprints, we have integrated medRxiv into our submission process for the rapid sharing of new medical research.
Call for feedback: The 2021 eLife survey
Share your views on how to improve research culture and publishing
Webinar Report: Promoting inclusion in science
In this webinar our speakers discussed how you can promote inclusivity within your institution.
Event Report: A second Aging, Geroscience and Longevity Symposium
Catch up on our second online symposium in which eLife authors showcased their research published in the Aging, Geroscience and Longevity Special Issue.
eLife Latest: Changes to our publication fee
The eLife fee for publication will increase on April 5, 2021; authors may request a waiver for any reason.
Be the first to read new articles from eLife
Sign up for alerts
Please leave this field empty
Back to top